Ionic Capital Management LLC Eli Lilly & CO Call Options Transaction History

Ionic Capital Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $926,568 - $1.15 Million	1,200 New	1,200 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $7.41 Million - $8.45 Million	25,000 New	25,000 $8.08 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $4.24 Million - $4.9 Million	-29,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $3.96 Million - $4.76 Million	29,000 New	29,000 $4.76 Million

4,012

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ionic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ionic Capital Management LLC with notifications on news.